January 9, 2013
  • Tamiflu Approved for Use in Infants Older Than 2 Weeks

    Tamiflu has been approved for use in infants as young as 2 weeks old with new-onset influenza, but dosages must be individually calculated by weight for patients less than a year old. Making sure caregivers have the right tools to do that falls to pharmacists. Here are the details.

  • Common Antidepressant Drug Could Prevent
    Diabetes Complications

    In a discovery that surprised researchers, the drug marketed as Paxil had benefit far beyond its approved use for depression. Unique among antidepressants, paroxetine was also found to help mitigate vascular complications of diabetes. Read on to find out more.

  • CDC: Pharmacists Should Counsel on Safe Handling
    of Buprenorphine

    Buprenorphine can be invaluable in treating opioid addiction, but more widespread prescribing has dramatically increased adverse consequences from unintentional exposure. Find out what role pharmacists are being asked to play in educating users on safe handling of the drug.

  • Pediatricians Call for Thimerosal to Remain as
    Vaccine Preservative

    The mercury-based preservative thimerosal has been at the center of controversy for decades, but numerous studies have failed to prove significant harm from the vaccine addictive. Now, the American Academy of Pediatrics is joining with other health groups worldwide to fight a ban on the use of the preservative in vaccines. Here’s why and how that ban would affect multiuse vaccine vials.

U.S. Pharmacist Social Connect